PROGERIA RESEARCH FOUNDATION, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for PROGERIA RESEARCH FOUNDATION, INC..The latest application filed is for "lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis".

Company Profile

3.12.6

PROGERIA RESEARCH FOUNDATION, INC. - Peabody MA US
Progeria Research Foundation, Inc. - Ann Arbor MI US
The Progeria Research Foundation, Inc. - N/A
Progeria Research Foundation, Inc. - The University of North Carolina at Chapel Hill
Progeria Research Foundation, Inc. - Chapel Hill NC
The Progeria Research Foundation, Inc. - Albany NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA Grant 10,398,721 - Kole , et al. Sep	2019-09-03
Lmna Gene And Its Involvement In Hutchinson-gilford Progeria Syndrome (hgps) And Arteriosclerosis App 20160002307 - Eriksson; B. Maria H. ; et al.	2016-01-07
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis Grant 9,115,400 - Eriksson , et al. August 25, 2	2015-08-25
Farnesyltransferase Inhibitors For Treatment Of Laminopathies, Cellular Aging And Atherosclerosis App 20150018381 - GORDON; Leslie B. ; et al.	2015-01-15
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis Grant 8,828,356 - Gordon , et al. September 9, 2	2014-09-09
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis Grant 8,691,501 - Gordon , et al. April 8, 2	2014-04-08
Lmna Gene And Its Involvement In Hutchinson-gilford Progeria Syndrome (hgps) And Arteriosclerosis App 20140072973 - Eriksson; B. Maria H. ; et al.	2014-03-13
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis Grant 8,535,884 - Eriksson , et al. September 17, 2	2013-09-17
Farnesyltransferase Inhibitors For Treatment Of Laminopathies, Cellular Aging And Atherosclerosis App 20130203799 - Gordon; Leslie B. ; et al.	2013-08-08
Farnesyltransferase Inhibitors For Treatment Of Laminopathies, Cellular Aging And Atherosclerosis App 20120329066 - Gordon; Leslie B. ; et al.	2012-12-27
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis Grant 8,257,915 - Gordon , et al. September 4, 2	2012-09-04
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis Grant 8,034,557 - Eriksson , et al. October 11, 2	2011-10-11
Farnesyltransferase Inhibitors For Treatment Of Laminopathies, Cellular Aging And Atherosclerosis App 20110027806 - GORDON; LESLIE B. ; et al.	2011-02-03
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis Grant 7,838,531 - Gordon , et al. November 23, 2	2010-11-23
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis Grant 7,297,492 - Eriksson , et al. November 20, 2	2007-11-20

Company Registrations

CAGE Code	3RTH7	PROGERIA RESEARCH FOUNDATION, INC., THE PRF
S.A.M. Registration	3RTH7 [92969927]	PROGERIA RESEARCH FOUNDATION, INC., THE PRF

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.